Mouwasat Medical Services
4002 · TASI — Main Market · 2026-07-29
Download report (PDF)
Snapshot Price 66.55 SAR
Market cap 13.31B SAR
P/E 16.19×
P/B 3.52×
ROE 21.76%
Dividend yield 4.51%
Revenue CAGR 11.35%
Valuation (Hajras) Fair value 43.36 SAR
Rating overvalued
Upside/(downside) -34.85%
DCF 69.82
DDM 43.36
Graham 40.52
Discount rate 10.13%
DCF growth 8.00%
Financials SAR FY22 FY23 FY24 FY25 Revenue 2.33B 2.71B 2.88B 3.22B Net income 599.31M 657.69M 645.76M 822.04M EPS 3.00 3.29 3.23 4.11 DPS 1.38 1.50 1.75 3.00 Equity 2.92B 3.28B 3.57B 3.78B
Analyst Price Targets Consensus (median) — SAR
Range — – — SAR
Aljazira Capital (hold) 209.00 SAR
This report is for informational purposes only and is not investment advice. Sources: Hajras valuation & financials, Yahoo/SEC EDGAR, and investment-house targets.